All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Curcumin / BSA:New approach for hepatocellular carcinoma treatment

Author(s): Faten Zahran, Essam Mady, Osama Yasein, Akaber T.Keshta

The systemic availability of curcumin is very low after oral administration; this limits their therapeutic potential. This study aims to increase the bioavailability of curcumin; the highest reproducible solubility modality will be applied on an experimental carcinogenesismodels in order to evaluate its chemo-preventive, chemotherapeutic effects and antitumor potential. We found that administrating of curcumin (200mg/kg I.P. bound to 5%BSA in PBS, pH7.4) results in a significant inhibitory effect on tumor in vivo.An anti-oxidant effect and anti-tumor effect of curcumin in vivo was observed. A significant reduction in anti-oxidants and tumor markers levels in tumor treated animals when compared with untreated ones. As well as Bcl2 expression was reduced. Conclusion: curcumin bound BSA has a strong inhibitory activity against tumors. The anti-tumor mechanism may be mediated by preventing oxidative damage and induction of apoptosis improved animalsÂ’ chances of survival and they become healthier.


Share this